| scholarly article | Q13442814 |
| P2093 | author name string | Zhipeng Zhang | |
| Weijia Sun | |||
| Yebin Lu | |||
| Hongxi Chen | |||
| Tiecheng Feng | |||
| P2860 | cites work | Update on familial pancreatic cancer | Q57953769 |
| Pancreatic cancer | Q87198210 | ||
| Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages | Q21092323 | ||
| Cancer genome landscapes | Q22242276 | ||
| Recent progress in pancreatic cancer | Q24626346 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Long non-coding RNA and chromatin remodeling | Q26801406 | ||
| Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-β signaling | Q28115541 | ||
| A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assembly | Q28116056 | ||
| Long non-coding RNAs: insights into functions | Q28131764 | ||
| p21 is a universal inhibitor of cyclin kinases | Q28257305 | ||
| Tobacco and the risk of pancreatic cancer: a review and meta-analysis | Q28264581 | ||
| Occupational exposure to carcinogens: Benzene, pesticides and fibers (Review) | Q28393587 | ||
| Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies | Q29620390 | ||
| Pathology and molecular genetics of pancreatic neoplasms | Q33581119 | ||
| LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1/E2F3 pathway. | Q33677983 | ||
| Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer | Q33915812 | ||
| Risk factors for pancreatic adenocarcinoma and prospects for screening. | Q33916380 | ||
| Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection | Q34093790 | ||
| Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. | Q34250010 | ||
| RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites | Q34253195 | ||
| The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma | Q34459058 | ||
| Genetics and biology of pancreatic ductal adenocarcinoma. | Q34567515 | ||
| Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection | Q34620078 | ||
| Alternative splicing and co-option of transposable elements: the case of TMPO/LAP2α and ZNF451 in mammals | Q35829675 | ||
| Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis | Q36413404 | ||
| Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17. | Q36473179 | ||
| A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells | Q36773207 | ||
| Identifying people at a high risk of developing pancreatic cancer | Q36831321 | ||
| The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway | Q37736760 | ||
| Perineural invasion and associated pain in pancreatic cancer | Q37937421 | ||
| SUMO rules: regulatory concepts and their implication in neurologic functions. | Q38132691 | ||
| Cell cycle inhibitors for the treatment of NSCLC. | Q38199197 | ||
| Functional roles of long non-coding RNA in human breast cancer | Q38240022 | ||
| The lncRNA-MYC regulatory network in cancer | Q38241414 | ||
| LncRNA: a link between RNA and cancer | Q38243587 | ||
| Long noncoding RNA HOTAIR involvement in cancer | Q38244306 | ||
| High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression | Q38700224 | ||
| Long Noncoding RNA PVT1 Promotes EMT and Cell Proliferation and Migration Through Downregulating p21 in Pancreatic Cancer Cells | Q38709746 | ||
| LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR. | Q38745036 | ||
| Census and evaluation of p53 target genes. | Q38911126 | ||
| LncRNA-mediated regulation of cell signaling in cancer. | Q39366670 | ||
| Long noncoding RNAs: lincs between human health and disease | Q39376908 | ||
| Long non-coding RNAs: New biomarkers for prognosis and diagnosis of colon cancer | Q39393570 | ||
| Long Noncoding RNA and Cancer: A New Paradigm | Q39431288 | ||
| ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator | Q39957218 | ||
| Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma | Q40341155 | ||
| Classical swine fever virus Shimen infection increases p53 signaling to promote cell cycle arrest in porcine alveolar macrophages | Q41348469 | ||
| A screen for inducers of bHLH activity identifies pitavastatin as a regulator of p21, Rb phosphorylation and E2F target gene expression in pancreatic cancer | Q41593086 | ||
| Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease | Q41628867 | ||
| Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection | Q42254406 | ||
| LncRNA UCA1 in anti-cancer drug resistance | Q42362804 | ||
| Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma | Q45360884 | ||
| Computer-aided biomarker discovery for precision medicine: data resources, models and applications. | Q45943371 | ||
| BioSeq-Analysis: a platform for DNA, RNA and protein sequence analysis based on machine learning approaches | Q47173127 | ||
| Smad3 and Bmal1 regulate p21 and S100A4 expression in myocardial stromal fibroblasts via TNF-α. | Q47822539 | ||
| Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation. | Q48235043 | ||
| The TLR3 Agonist Inhibit Drug Efflux and Sequentially Consolidates Low-Dose Cisplatin-Based Chemoimmunotherapy while Reducing Side Effects. | Q48852503 | ||
| Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway. | Q50885602 | ||
| The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study. | Q51084560 | ||
| lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity. | Q51093479 | ||
| Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells. | Q52762044 | ||
| Pancreatic Cancer | Q54135367 | ||
| Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population. | Q54361653 | ||
| P433 | issue | 4 | |
| P921 | main subject | invasive ductal carcinoma | Q1671685 |
| pancreatic ductal carcinoma | Q8263002 | ||
| pancreatic ductal adenocarcinoma | Q18555956 | ||
| P304 | page(s) | 1224-1234 | |
| P577 | publication date | 2018-02-28 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451. | |
| P478 | volume | 52 |
Search more.